Cabot Corporation research snapshot
CBT AI stock analysis rates Cabot Corporation as a solid specialty chemicals and performance materials business with a wide product moat in carbon black and fumed metal oxides. At the July 10, 2026 data cutoff, CBT traded at $87.32 with a $4.51 billion market cap, a trailing P/E near 16.5x, and a forward P/E near 10.6x. The CBT AI stock forecast uses scenarios because specialty chemical earnings depend on tire demand, battery materials adoption, industrial production, and raw material costs. The stock has rallied from 2025 lows below $60 toward the 52-week high near $94.53, so the current price offers a moderate margin of safety if earnings grow, but limited upside if industrial demand softens.
Current price
$87.32
Market cap
$4.51 billion verified market cap
AI score
64 / 100
Rating
Solid specialty chemicals franchise, reasonable valuation, moderate cyclical risk
Trend status
Strong uptrend from 2025 lows, near 52-week high and approaching all-time high territory
Data cutoff (updated weekly)
July 10, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cabot sells essential carbon black, specialty compounds, fumed metal oxides, and conductive additives that are used in tires, coatings, adhesives, batteries, inks, and insulation. Customers depend on these materials for manufacturing, and switching suppliers requires reformulation work. | High |
| Moat | Scale manufacturing, customer qualification processes, proprietary technology in carbon black and fumed silica grades, and 140 years of industry relationships create a moderate moat. The moat is strongest in tire carbon black and weakest in commodity-adjacent chemical grades where price competition is higher. | Medium-high |
| Management | Sean Keohane has been CEO since 2019 and has focused Cabot on specialty applications, battery materials growth, and cost discipline. The management team has navigated raw material inflation, supply chain shifts, and tariff uncertainty, but capital allocation during the next cycle will be a better test. | Medium |
| Financial trend | Revenue has grown from around $2.6 billion in FY2020 to approximately $3.7 billion in FY2025. Net income has improved from pandemic lows, and free cash flow generation has been solid at over $370 million on a TTM basis. Profit margins near 8% are in line with specialty chemical peers. | High |
| Valuation | At $87.32, CBT trades at roughly 16.5x TTM EPS and 10.6x forward EPS, near 2.7x book value, and about 1.2x sales. These multiples are reasonable for a specialty chemical company with moderate growth and solid free cash flow yield near 8.3%. The three-scenario model shows a base case near $93.50. | High |
| Technical trend | CBT has been in a strong uptrend from early 2025 lows below $60 toward the 52-week high near $94.53. The stock is approaching the all-time high of $117.46 set in November 2024. RSI and momentum indicators are not in an obvious overbought zone but warrant attention at current levels. | Medium |
| Risk level | Key risks are industrial demand softness, tire production cycles, raw material cost volatility, tariff exposure on international operations, battery materials adoption timing, and a moderate debt-to-equity ratio near 78%. The short float of 6.24% adds moderate bearish positioning. | Medium-high |
| AI confidence | Currently reported and cross-verified financial data has high confidence. Forward estimates, technical levels, and scenario valuation have medium confidence because they depend on assumptions about industrial demand, tire production, raw material costs, and investor sentiment. | Medium-high data confidence |
| Investment certainty | Cabot is a durable business at a moderate valuation, but the near-term price reflects the specialty chemical cycle, battery materials adoption, and raw material volatility. The current price is closer to the base case than to a deep value entry. | Medium |
CBT AI stock forecast
The CBT AI stock forecast uses the July 10, 2026 price reference of $87.32, TTM EPS near $5.30, and a three-year scenario model from the Pineify financial_rigor.py tool. The audited model produced a bearish area near $56, a base area near $94, and a bullish area near $145. The base case is close to the current price, which means the stock is reasonably priced for steady execution but leaves limited room for multiple expansion.
$120 to $145
More likely if battery materials revenue accelerates, tire demand stays strong globally, Cabot gains share in specialty applications, and the market re-rates the stock toward 16-18x forward earnings as growth expectations improve.
$85 to $100
More likely if EPS compounds in the high-single-digit range, industrial demand remains stable but not booming, and the market values CBT near 13-15x forward earnings in line with the specialty chemical peer group.
$50 to $65
More likely if tire production slows, industrial demand weakens, raw material cost pressures compress margins, battery materials adoption takes longer than expected, or the market re-rates CBT toward 10-11x forward earnings.
CBT AI technical analysis
CBT AI technical analysis shows a strong uptrend in place as of the July 10, 2026 data cutoff. The stock traded near $87.32 after a rally from 52-week lows near $58.33 toward the 52-week high near $94.53 and the all-time high near $117.46 from November 2024. Key levels to watch are support near $80 and $70, and resistance near $94 and $100. The 50-day moving average and 200-day moving average are both above the current price after the sustained rally.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $87.32 | Current market-data reference used for valuation and market-cap checks at the July 10, 2026 data cutoff. |
| Immediate support | $80 to $82 | This area represents a near-term pullback zone where buyers have previously stepped in during the current uptrend. |
| Deeper support | $70 to $72 | This area corresponds to a significant prior resistance-turned-support level and would represent a normal trend correction. |
| Near resistance | $94 to $96 | The 52-week high near $94.53 is the immediate resistance zone bulls need to clear for a test of all-time highs. |
| Next resistance | $100 to $105 | The psychological $100 round number plus the next price cluster before the all-time high near $117.46. |
| Moving averages | 50-day and 200-day both below current price | The stock trades above both key moving averages, confirming the uptrend. The distance above the 200-day average is moderate and not yet extended. |
| Momentum | Moderately positive, not overbought | The rally from $58 has been sustained rather than parabolic, which suggests momentum can continue. RSI is not at extreme levels. |
| Volume | Average daily volume near 510,000 shares | Volume has been below average on the recent consolidation, which can precede a directional move. Watch for volume confirmation on any breakout above $94. |
| Volatility | Watch Q3 FY2026 earnings, tire demand indicators, and raw material costs | The next earnings update in early August 2026 and any change in guidance for Reinforcement Materials or Performance Chemicals demand can move CBT more than normal daily noise. |
| Invalidation | Close below $75, then below $60 for the major trend | A close below $75 would weaken the short-term uptrend. A break below $60 near the 52-week low would challenge the larger trend framework. |
CBT AI trading strategy
The CBT AI trading strategy below is a rules-based research framework, not personal advice. It connects trend behavior with tire demand, battery materials adoption, specialty chemical pricing, and valuation discipline.
Watch for CBT to clear the $94 to $96 resistance zone with above-average volume while Q3 FY2026 results show stable Reinforcement Materials demand and continued growth in Performance Chemicals battery materials sales.
A failed breakout above $94 followed by a close below $82 should reduce trend confidence, especially if industrial production data or tire demand indicators weaken.
If CBT pulls back toward the $70 to $75 zone without a fundamental earnings downgrade, compare the lower price with Cabot free cash flow yield, book value, and the historical specialty chemical valuation range.
Do not treat a pullback as attractive if tire production slows meaningfully, raw material costs compress margins, or the company signals a weaker outlook for the Reinforcement Materials segment.
Track Reinforcement Materials volumes and pricing, Performance Chemicals specialty product mix, battery materials revenue trajectory, raw material cost trends (carbon black feedstock), free cash flow conversion, debt levels, and share repurchase activity.
Position sizing should reflect that CBT is a specialty chemical cyclical with a durable but not impregnable moat, not a high-growth technology compounder.
Investment research summary
Customers pay Cabot because tire manufacturers, coating producers, battery makers, and industrial customers need consistent quality carbon black, fumed metal oxides, and conductive additives. Reformulating a tire or coating to use a different supplier material is costly and time-consuming, which creates recurring revenue from qualified customer relationships.
The moat is strongest in tire-grade carbon black where Cabots scale, manufacturing know-how, and customer qualification processes create real switching costs. The moat is moderate in specialty carbons and fumed metal oxides where proprietary technology and application expertise differentiate Cabot from commodity producers. Brand and network effects are limited in industrial chemicals.
The thesis fails if tire demand declines from a global industrial slowdown, if electric vehicle adoption changes the carbon black demand profile, if raw material price swings compress margins faster than Cabot can adjust pricing, or if the battery materials business takes longer to scale than the market expects.
Sean Keohane has led Cabot since 2019 and has shifted the portfolio toward higher-margin specialty applications and battery materials. The management team has managed through trade policy uncertainty, the COVID cycle, and raw material volatility. Future capital allocation decisions during the next down cycle will provide a clearer picture of management skill.
Cabot benefits from global tire production, industrial activity, infrastructure investment, and the growing need for specialty chemicals in batteries, coatings, and electronics. The offset is that chemicals are tied to industrial cycles, raw material availability, energy costs, and trade regulation changes that can affect margins and volumes.
At $87.32, CBT trades at a reasonable valuation with trailing P/E near 16.5x, forward P/E near 10.6x, and free cash flow yield near 8.3%. The base-case target from the three-scenario model is near $93.50, suggesting modest upside if execution stays on track. The margin of safety improves near the $70 zone and becomes limited above the $94 52-week high.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CBT quote reference | $87.32 close price on July 10, 2026; $87.92 after-hours | Yahoo Finance CBT quote page | July 10, 2026 |
| Market capitalization verification | $4.51 billion reported, $4.51 billion calculated from $87.32 x 51.62 million shares | Pineify financial_rigor.py verification tool | July 10, 2026 |
| Shares outstanding | 51.62 million shares outstanding | Barchart CBT key statistics | July 10, 2026 |
| TTM revenue and net income | TTM revenue near $3.58 billion (Yahoo), FY2025 revenue $3.71 billion (TradingView). TTM net income $281 million (Yahoo), FY2025 $327 million (TradingView). Difference reflects TTM vs fiscal year cutoff. | Yahoo Finance key statistics and TradingView CBT financials cross-check | July 10, 2026 |
| Valuation ratios verification | 16.5x TTM P/E, 2.7x book value, 1.2x sales, 8.3% FCF yield, 2.09% dividend yield from cross-verified inputs | Pineify financial_rigor.py and Yahoo Finance statistics | July 10, 2026 |
| Three-scenario valuation model | Bullish: $145 / Base: $94 / Bearish: $56 using 15%/8%/2% EPS growth and 18x/14x/10x terminal PE over 3 years | Pineify financial_rigor.py three-scenario valuation tool | July 10, 2026 |
| Cash and debt context | $252 million total cash, 77.71% debt-to-equity ratio, enterprise value of $5.38 billion | Yahoo Finance key statistics and Barchart profile cross-check | July 10, 2026 |
| Management and governance | Sean D. Keohane has been President and CEO since September 2019. He previously held senior leadership roles at Cabot and was President of the Reinforcement Materials segment. | Cabot Corporation investor relations and SEC filings | July 10, 2026 |
| Technical data and trading metrics | 52-week range $58.33 to $94.53, all-time high $117.46 (Nov 2024), beta 0.82, average volume 510,896 shares, short float 6.24% | Yahoo Finance and Barchart CBT statistics | July 10, 2026 |
| Analyst consensus | Average analyst target $90.33 (range $70 to $102), Mizuho Neutral rating, Argus Hold rating | Yahoo Finance CBT analysis page | July 10, 2026 |
| Dividend and shareholder returns | Quarterly dividend $0.47 per share, annualized $1.82, yield 2.09%, 26.3% payout ratio. Consecutive dividend payments for many years. | Barchart CBT dividends and Yahoo Finance statistics | July 10, 2026 |
This CBT AI stock analysis is for informational and educational use only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast ranges are scenario estimates based on available public data as of July 10, 2026, and they can be wrong if fundamentals, market prices, tire demand, industrial production, battery materials adoption, raw material costs, or investor sentiment change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
